Translated automatically – community improvements welcome.
Cannabigerol
Cannabigerol (CBG) is a non-psychoactive phytocannabinoid found in cannabis. It primarily acts as a CB2 agonist and CB1 modulator and influences various TRP channels. Due to its anti-inflammatory and neuroprotective properties, it is being investigated in research for potential therapeutic applications. CBG shows a low risk of side effects and is considered a safe component of cannabis extracts.
Mechanism of Action
- CB1 modulator
- CB2 agonist
- TRP channel modulation
Names / Identifiers
IUPAC: Cannabigerol
Mechanism of Action
Cannabigerol wirkt als Antagonist an den Cannabinoid-Rezeptoren CB1 und CB2, was zu einer Modulation der Endocannabinoid-System-Aktivität führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Pregnancy
- Breastfeeding
- Pre-existing conditions of the central nervous system
Known Risks
- unknown
- Allgemein als sicher angesehen, jedoch sind Langzeitwirkungen und Wechselwirkungen nicht vollständig erforscht.
Safer Use
- Start with a low dose
- Pay attention to individual reactions
Harm reduction tips do not replace medical advice.
Known Interactions
- May interact with other cannabinoids
- Possible interactions with medications affecting the central nervous system
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.